Literature DB >> 7790028

Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.

J Champsi1, L S Young, L E Bermudez.   

Abstract

The Mycobacterium avium complex comprises intracellular bacteria associated with disseminated infection in patients with acquired immune deficiency syndrome (AIDS). Immune defects that lead to infection are unknown but cytokines appear to play an important role in the immunomodulation of host defence mechanisms. We evaluated the cytokine profiles seen temporally after murine M. avium infection. Spleen cells were obtained from M. avium-infected C57BL/6 mice and uninfected mice at weeks 1, 2, 3, 4 and 5. Cells were cultured in vitro and subsequently pulsed with killed M. avium. Supernatants were collected from the cultured splenic cells and the concentrations of interleukin-6 (IL-6), transforming growth factor-beta 1 (TGF-beta 1) and tumour necrosis factor-alpha (TNF-alpha) were measured. TGF-beta 1 was detected at week 1, followed by IL-6 production at week 2. Elevated TNF-alpha levels were observed at week 3. The addition of polyclonal anti-TGF-beta 1 antibody to M. avium-infected peritoneal macrophages in the presence of splenic cell supernatants from weeks 1, 3 and 5 led to decreased bacterial counts compared to controls. Anti-IL-6 antibody did not have any effect on macrophage anti-mycobacterial activity. Concurrently, we observed decreased expression of TNF-alpha receptors on infected macrophages. We propose that the early elevated levels of TGF-beta 1, a known suppressor of macrophage function, in conjunction with down-regulation of TNF-alpha receptors may help explain the suboptimal macrophage response to TNF-alpha, leading to impaired anti-mycobacterial activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790028      PMCID: PMC1415166     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.

Authors:  L E Bermudez; G Covaro; J Remington
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

2.  A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells.

Authors:  A Nakagawara; C F Nathan
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

3.  Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.

Authors:  E H De Titto; J R Catterall; J S Remington
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

4.  Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.

Authors:  L E Bermudez
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

5.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

6.  Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.

Authors:  L E Bermudez; M Wu; M Petrofsky; L S Young
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor.

Authors:  S K Furney; P S Skinner; A D Roberts; R Appelberg; I M Orme
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.

Authors:  L E Bermudez; L S Young
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome.

Authors:  C C Hawkins; J W Gold; E Whimbey; T E Kiehn; P Brannon; R Cammarata; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

10.  Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice.

Authors:  L E Bermudez; J Champsi
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more
  26 in total

1.  Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.

Authors:  L E Bermudez; J Goodman; M Petrofsky
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 2.  Why intracellular parasitism need not be a degrading experience for Mycobacterium.

Authors:  D G Russell; S Sturgill-Koszycki; T Vanheyningen; H Collins; U E Schaible
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

3.  Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases.

Authors:  L E Bermudez; A Parker; M Petrofsky
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

4.  Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.

Authors:  A Corti; L Fattorini; O F Thoresen; M L Ricci; A Gallizia; M Pelagi; Y Li; G Orefici
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Interleukin-2 and loss of immunity in experimental Mycobacterium avium infection.

Authors:  Stuart I Mannering; Christina Cheers
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.

Authors:  Marinka Kartalija; Alida R Ovrutsky; Courtney L Bryan; Gregory B Pott; Giamila Fantuzzi; Jacob Thomas; Matthew J Strand; Xiyuan Bai; Preveen Ramamoorthy; Micol S Rothman; Vijaya Nagabhushanam; Michael McDermott; Adrah R Levin; Ashley Frazer-Abel; Patricia C Giclas; Judith Korner; Michael D Iseman; Leland Shapiro; Edward D Chan
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

7.  Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium.

Authors:  I S Eriks; C L Emerson
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.

Authors:  L E Bermudez; M Petrofsky
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

9.  Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology.

Authors:  J Turner; A A Frank; J V Brooks; P M Marietta; I M Orme
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

10.  Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria.

Authors:  J A McGarvey; D Wagner; L E Bermudez
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.